Menu

Infographic: A Body Without Food

Mounting evidence suggests that intermittent fasting causes significant changes to various organs and tissue types.

May 31, 2017
Bob Grant

© AMPON AKEARUNRUNG/SHUTTERSTOCK.COM

The fasting signal likely starts in the liver, the body’s central command for metabolism. But through changes in gene expression and alterations in complex enzymatic pathways, the effects of food deprivation spread throughout the body, from the brain and visceral fat to the muscles and more.

LIVER
Fasting and time-restricted feeding increases insulin sensitivity, decreases insulin resistance, and lowers blood glucose levels. With prolonged periods of fasting, the liver’s glycogen stores become depleted, and visceral fat is tapped as an energy source, which releases ketones that can be metabolized by neurons and muscle cells.
 
IMMUNE SYSTEM
Periodic fasting reprograms T-cell populations, tamping down autoimmunity and rescuing immunosenescence. A lack of incoming calories appears to prune away autoimmune T cells, and with refeeding, hematopoietic stem cells are activated to replace T cells, lymphocytes, and other white blood cells. Several fasting studies have also pointed to a decrease in inflammatory cytokines.
 
HEART
Because triglycerides become mobilized for energy in the absence of incoming dietary calories, blood lipid levels tend to go down in a fasting body. Researchers have also seen decreases in blood pressure in fasting animals. In some animal studies of fasting, investigators have recorded decreases in cholesterol.
 
BRAIN
Intermittent fasting has improved memory, learning, and neurogenesis in rodents, and has been shown to repair some neurons in mouse models of ischemic stroke.
© ISTOCK.COM/PUKRUFUS/MARIYALLCANCER
By making tumor cells more susceptible to chemotherapeutic agents while protecting healthy cells from the treatment’s toxicity, intermittent fasting is showing promise in slowing the progression of breast cancers and melanoma in mice.

Read the full story.

March 2019

Going Under

Dissecting the effects of anesthetics

Marketplace

Sponsored Product Updates

StemExpress Announces New Distribution Partnerships
StemExpress Announces New Distribution Partnerships
To continue meeting the needs of clients around the world, StemExpress announces the expansion of its global distribution network to include the Asia Pacific and Australia, adding to their existing networks in North America, Europe, and North Africa.  
Lonza Expands Mycoplasma Detection Portfolio with New Luminometer Designed to Accelerate and Simplify Testing
Lonza Expands Mycoplasma Detection Portfolio with New Luminometer Designed to Accelerate and Simplify Testing
Lonza has further strengthened its extensive mycoplasma detection portfolio with the addition of the Lucetta™ 2 Luminometer, a single-tube system designed to simplify and accelerate mycoplasma detection in cell cultures. Pharmaceutical, biotechnology and academic researchers can now rely on this compact, portable and easy-to-use instrument to run Lonza’s MycoAlert™ Mycoplasma Detection Assays and obtain highly reliable results within just 20 minutes.
FUJIFILM Irvine Scientific Introduces Low Hydrolysate Medium For Insect Cell Expression Systems
FUJIFILM Irvine Scientific Introduces Low Hydrolysate Medium For Insect Cell Expression Systems
FUJIFILM Irvine Scientific, Inc., a world leader in the optimization and manufacture of cell culture media, today announced the introduction of IS Sf Insect medium. The serum-free, animal component-free, low hydrolysate medium is formulated for scalability for the consistent growth and yields of proteins, viral vectors and viral-like particles using baculovirus expression systems (BEVS), in Sf9 and Sf21 cells.
Improving Preclinical Discovery of CRISPR Engineered Immune Cell Therapies
Improving Preclinical Discovery of CRISPR Engineered Immune Cell Therapies
There is an urgent need to characterize the potency and efficacy of CRISPR-Cas9-modified inducible pluripotent stem cell-derived natural killer cells for preclinical cancer immunotherapy research. IsoPlexis' single-cell proteomics system addresses this challenge by connecting each immune cell to cytokine secretion and thereby correlating them to in vivo outcome across a range of disease areas.